Molecular Targeting Technologies,Inc Employee Directory

Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees

Molecular Targeting Technologies, Inc. is a clinical-stage pharmaceutical company focused on theranostics for rare cancers. Based in West Chester, Pennsylvania, it traces its roots to a Centocor spinoff and leverages a decade of collaborative research and a broad scientific network. Its portfolio comprises NIH-licensed radiopharmaceuticals for both therapy and diagnostic imaging, with several assets advancing in clinical studies. In development, EBTATE targets gastroenteropancreatic neuroendocrine tumors and Hürthle cell thyroid tumors, with early human testing indicating safety and improved effectiveness over some competitors, and US trials underway at Memorial Sloan Kettering Cancer Center. The pipeline also includes EBRGD for αvβ3-expressing tumors, including glioblastoma multiforme and non-small cell lung cancer, as well as FGA and TDURA imaging agents focused on tumor response and cell death.

Sign up for free to view info

Company overview Email format